Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangjun Nie

Showing results (11-20 of 326) with videos related to

Pageof 33
Sort By:
Advanced Drug Delivery Reviews|September 16, 2021
Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesiclesJing Wang, Motao Zhu, Guangjun Nie
Human Vaccines & Immunotherapeutics|December 9, 2014
Applications of nanomaterials as vaccine adjuvantsMotao Zhu, Rongfu Wang, Guangjun Nie
Nature Protocols|December 14, 2020
Responsive and activable nanomedicines for remodeling the tumor microenvironmentYinlong Zhang, Xuexiang Han, Guangjun Nie
Nanomedicine (London, England)|July 11, 2013
Nanotechnological strategies for therapeutic targeting of tumor vasculatureYanping Ding, Suping Li, Guangjun Nie
Science China. Life Sciences|October 31, 2012
Antineoplastic activities of Gd@C₈₂(OH)₂₂ nanoparticles: tumor microenvironment regulationYiye Li, Yanhuan Tian, Guangjun Nie
National Science Review|February 9, 2026
Propulsion-enhanced chemotaxis drives bifunctional enzymatic nanorobots deep into tumorsSuping Li, Guangjun Nie, Yuliang Zhao
Small (Weinheim an Der Bergstrasse, Germany)|December 11, 2012
Understanding the particokinetics of engineered nanomaterials for safe and effective therapeutic applicationsMotao Zhu, Sarah Perrett, Guangjun Nie
Nature Protocols|July 25, 2022
Nanocarriers based on bacterial membrane materials for cancer vaccine deliveryXiao Zhao, Ruifang Zhao, Guangjun Nie
Medical Review (2021)|January 18, 2024
Intelligent nanomaterials for cancer therapy: recent progresses and future possibilitiesJing Wang, Yuliang Zhao, Guangjun Nie
Journal of Alzheimer'S Disease : JAD|March 28, 2012
Overexpression of human wild-type amyloid-β protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cellsLi Wan, Guangjun Nie, Jie Zhang, et al.
Pageof 33

Showing results (11-20 of 326) with videos related to

Sort By:
Pageof 33
Advanced Drug Delivery Reviews|September 16, 2021
Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesiclesJing Wang, Motao Zhu, Guangjun Nie
Human Vaccines & Immunotherapeutics|December 9, 2014
Applications of nanomaterials as vaccine adjuvantsMotao Zhu, Rongfu Wang, Guangjun Nie
Nature Protocols|December 14, 2020
Responsive and activable nanomedicines for remodeling the tumor microenvironmentYinlong Zhang, Xuexiang Han, Guangjun Nie
Nanomedicine (London, England)|July 11, 2013
Nanotechnological strategies for therapeutic targeting of tumor vasculatureYanping Ding, Suping Li, Guangjun Nie
Science China. Life Sciences|October 31, 2012
Antineoplastic activities of Gd@C₈₂(OH)₂₂ nanoparticles: tumor microenvironment regulationYiye Li, Yanhuan Tian, Guangjun Nie
National Science Review|February 9, 2026
Propulsion-enhanced chemotaxis drives bifunctional enzymatic nanorobots deep into tumorsSuping Li, Guangjun Nie, Yuliang Zhao
Small (Weinheim an Der Bergstrasse, Germany)|December 11, 2012
Understanding the particokinetics of engineered nanomaterials for safe and effective therapeutic applicationsMotao Zhu, Sarah Perrett, Guangjun Nie
Nature Protocols|July 25, 2022
Nanocarriers based on bacterial membrane materials for cancer vaccine deliveryXiao Zhao, Ruifang Zhao, Guangjun Nie
Medical Review (2021)|January 18, 2024
Intelligent nanomaterials for cancer therapy: recent progresses and future possibilitiesJing Wang, Yuliang Zhao, Guangjun Nie
Journal of Alzheimer'S Disease : JAD|March 28, 2012
Overexpression of human wild-type amyloid-β protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cellsLi Wan, Guangjun Nie, Jie Zhang, et al.
Pageof 33